Anne Huynh
Overview
Explore the profile of Anne Huynh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
2025
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Grand S, Villemonteix J, Daguindau E, Fort M, Caillat-Zucman S, Allain V, et al.
Hemasphere
. 2025 Feb;
9(2):e70088.
PMID: 39949376
Donor lymphocyte infusion (DLI) prevents acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) relapses following hematopoietic stem cell transplantation. Given the life-threatening toxicities such as graft versus host disease (GVHD),...
2.
Bertoli S, Berard E, Peterlin P, Guieze R, Desbrosses Y, Hicheri Y, et al.
Haematologica
. 2025 Feb;
PMID: 39911128
Not available.
3.
Soueges S, Faure E, Parize P, Lanternier-Dessap F, Lecuyer H, Huynh A, et al.
J Infect
. 2024 Dec;
90(1):106376.
PMID: 39681233
Introduction: The increase in the population of immunocompromised patients due to advances in management of end-stage diseases and transplants poses challenges in treating infections caused by multi-drug resistant (MDR) pathogens....
4.
Mediavilla C, dAveni M, Huynh A, Joris M, Masouridi-Levrat S, Nguyen S, et al.
Bull Cancer
. 2024 Sep;
112(1S):S54-S67.
PMID: 39242254
Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a potentially curative treatment for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). However, these transplants are complicated by a high rate of...
5.
Renders S, Ngoya M, Finel H, Rubio M, Townsend W, Schroers R, et al.
Blood Adv
. 2024 Aug;
8(21):5571-5578.
PMID: 39213423
Although broadly used, consolidative autologous hematopoietic stem cell transplantation (auto-HCT) for relapsed/refractory (R/R) T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) has never been specifically investigated. Here, we have analyzed outcomes of auto-HCT...
6.
Rabian F, Beauvais D, Marchand T, Furst S, Huynh A, Brissot E, et al.
Blood Adv
. 2024 Aug;
8(21):5493-5496.
PMID: 39207868
No abstract available.
7.
Arrieta-Bolanos E, Bonneville E, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, et al.
J Clin Oncol
. 2024 Aug;
42(28):3287-3299.
PMID: 39167735
PURPOSEHuman leukocyte antigen (HLA) mismatching can reduce survival of patients with blood cancer after hematopoietic cell transplantation (HCT). How recent advances in HCT practice, in particular graft-versus-host disease (GVHD) prophylaxis...
8.
Mohty R, Bazarbachi A, Labopin M, Esteve J, Kroger N, Cornelissen J, et al.
Bone Marrow Transplant
. 2024 Aug;
59(11):1534-1541.
PMID: 39143183
Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) mutations have uncertain prognostic implications in AML. We investigate the impact IDH1 and IDH2 mutations in AML patients undergoing allogeneic hematopoietic cell...
9.
Jeanselme P, Tavitian S, Lapierre L, Vergez F, Rigolot L, Huynh A, et al.
Leuk Lymphoma
. 2024 Aug;
65(13):2025-2030.
PMID: 39141583
Adult T-cell acute lymphoblastic leukemia has a poor outcome after relapse. Because the subtype of early T-cell precursor displays characteristics close of those of acute myeloid leukemia, such as epigenetic...
10.
Arrieta-Bolanos E, van der Burg L, Gedde-Dahl T, Robin M, Salmenniemi U, Kroger N, et al.
Blood
. 2024 Aug;
144(16):1747-1751.
PMID: 39102621
HLA-DP permissive mismatches can be assigned a direction according to their immunopeptidome divergence across core and noncore subsets. Noncore permissive graft-versus-host mismatches show significantly reduced risks of relapse without increased...